Multidrug Combinations against SARS-CoV-2 Using GS-441524 or Ivermectin with Molnupiravir and/or Nirmatrelvir in Reconstituted Human Nasal Airway Epithelia

<b>Background.</b> The emergence, global spread, and persistence of SARS-CoV-2 resulted in an unprecedented need for effective antiviral drugs. Throughout the pandemic, various drug development and treatment strategies were adopted, including repurposing of antivirals designed for other viruses alon...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Denise Siegrist, Hulda R. Jonsdottir, Mendy Bouveret, Bernadett Boda, Samuel Constant, Olivier B. Engler
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	MDPI AG 2024-09-01
Saila:	Pharmaceutics
Gaiak:	SARS-CoV-2 antivirals molnupiravir nirmatrelvir GS-441524 ivermectin
Sarrera elektronikoa:	https://www.mdpi.com/1999-4923/16/10/1262
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!